Perioperative medicine & outcomes

Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study

Crit CarePublished Retrospective cohort study

Main findingResult — go to the resultAdjusted hazard ratio 1.37 95% CI 1.25–1.48

Authors' conclusion

In this large real-world cohort, propofol maintenance anesthesia was associated with higher risks of postoperative delirium, long-term cognitive decline, and mortality compared with sevoflurane, particularly in physiologically vulnerable patients.

Study context

Population
Adults aged 60–80 years undergoing surgery with GA
Participants
45,545 vs 45,545
Exposure
Propofol vs sevoflurane maintenance anaesthesia
  • Propofoln = 45,545
  • Sevofluranen = 45,545reference
Outcome
Postoperative delirium
Methodological detailscomparative-effectiveness, multicentre, global federated health network, propensity-score matched (1:1), doubly robust Cox models
  • Comparative-effectiveness
  • Multicentre
  • Global federated health network
  • Propensity-score matched (1:1)
  • Doubly robust Cox models

Main finding

As reported in the abstract

Adjusted hazard ratio

1.37

95% CI 1.25–1.48

By group

Propofol vs Sevoflurane
aHR 1.37 (95% CI 1.25–1.48)

Observational data: associations, not effects.

Secondary outcomes

OutcomePropofolSevofluraneaHR (95% CI)
30-day mortality · propensity-score matched0.66%0.53%1.25 (1.05–1.48)
30-day mortality — Greatest excess on postoperative day 1
aHR 2.58

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study. Crit Care. Published 23 February 2026. doi:10.1186/s13054-026-05903-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.